Please login to the form below

Not currently logged in
Email:
Password:

Theravance hires BMS veteran Pasqualone

He joins as senior VP, operations

Theravance has named Frank Pasqualone as senior VP, operations.

Pasqualone joins the US-based biopharma from Bristol-Myers Squibb (BMS) where he most recently served as president of the intercontinental region, including Latin America, the Middle East and Africa.

He spent 25 years at BMS, where his roles included present of southern Europe and head of the company's US oncology/virology business. He also led diabetes marketing in the US at one stage.

Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.

This followed the approval last year of Theravance's antibiotic Vibativ (telavancin) to treat a hospital-acquired lung infection.

Since then, the company has been strengthening its senior business team, a process that has included the appointment of Jeff Jonker as senior VP, corporate and business development.

27th January 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...